INTELLIKINE LLC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	38
#2	EPO (European Patent Office)	26
#3	New Zealand	14
#4	WIPO (World Intellectual Property Organization)	12
#5	Australia	11
#6	Hong Kong	11
#7	Israel	11
#8	China	10
#9	Singapore	10
#10	Canada	9
#11	Republic of Korea	5
#12	Mexico	5
#13	South Africa	5
#14	Peru	3
#15	Chile	2
#16	EAPO (Eurasian Patent Organization)	2
#17	Malaysia	2
#18	Russian Federation	2
#19	Tunisia	2
#20	Ukraine	2
#21	Brazil	1
#22	Colombia	1
#23	Costa Rica	1
#24	Dominican Republic	1
#25	Ecuador	1
#26	Georgia	1
#27	Hungary	1
#28	India	1
#29	Philippines	1
#30	Slovenia	1
#31	Taiwan	1

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Climate change adaptation technologies
#5	Special acyclic compounds
#6	Climate change mitigation in goods production
#7	Organic chemistry methods
#8	Electrotherapy
#9	Microorganisms
#10	Analysing materials

Publication	Filing date	Title
AU2015201582A1	2015-03-27	Certain chemical entities, compositions and methods
AU2014203687A1	2014-07-04	Certain chemical entities, compositions and methods
US2016089371A1	2014-03-12	Combination of Kinase Inhibitors and Uses Thereof
CN105246482A	2014-03-12	Combination of kinase inhibitors and uses thereof
CN104363914A	2012-11-21	Enhanced treatment regimens using mtor inhibitors
WO2013078441A1	2012-11-21	Heterocyclic compounds and uses thereof
EP2776837A1	2012-11-12	Combination of kinase inhibitors and uses thereof
EP2776428A1	2012-11-12	Kinase inhibitor polymorphs
CN104080786A	2012-11-08	Treatment regimens by using multiple pharmaceutical agents
KR20140079368A	2012-08-10	Kinase inhibitor polymorphs
WO2012154610A1	2012-05-04	Reactive pi3k kinase inhibitors and uses thereof
WO2012154608A1	2012-05-04	Reactive mtor and pi3 kinase inhibitors and uses thereof
CA2836769A1	2012-05-04	The combination of paclitaxel and an mtor inhibitor for the treatment of a proliferative disorder
EP2678018A1	2012-02-23	Combination of kanase inhibitors and uses thereof
CN105078978A	2010-08-17	Heterocyclic compounds and uses thereof
SG187425A1	2009-01-05	Certain chemical entities, compositions and methods